1. Home
  2. ACHR vs APGE Comparison

ACHR vs APGE Comparison

Compare ACHR & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archer Aviation Inc.

ACHR

Archer Aviation Inc.

HOLD

Current Price

$6.04

Market Cap

4.7B

Sector

Industrials

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$66.62

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHR
APGE
Founded
2018
2022
Country
United States
United States
Employees
1148
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.0B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ACHR
APGE
Price
$6.04
$66.62
Analyst Decision
Buy
Buy
Analyst Count
6
11
Target Price
$12.00
$101.20
AVG Volume (30 Days)
25.6M
685.0K
Earning Date
03-02-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12,475.67
N/A
Revenue Next Year
$900.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.48
$26.20
52 Week High
$14.62
$84.56

Technical Indicators

Market Signals
Indicator
ACHR
APGE
Relative Strength Index (RSI) 37.82 39.60
Support Level N/A $66.00
Resistance Level $7.55 $71.18
Average True Range (ATR) 0.37 3.87
MACD -0.03 -0.36
Stochastic Oscillator 4.79 5.35

Price Performance

Historical Comparison
ACHR
APGE

About ACHR Archer Aviation Inc.

Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner. The company is building a platform to deliver aircraft, technologies, and services to customers world-wide across commercial and defense sectors.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: